CHE - Company ID 0000019584
The table below shows CHEMED CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $657.51M | $624.90M | $618.80M | $646.94M | $606.18M | $595.88M |
| Cost of revenue | $441.75M | $427.99M | $434.11M | $430.53M | $396.19M | $389.75M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
CHEMED CORP reported annual revenue of $2.53B for fiscal year 2025. That is up 4.1% from $2.43B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.58B (FY 2016) to $2.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $114.32M |
| $105.78M |
| $100.32M |
| $105.59M |
| $101.98M |
| $102.25M |
| Operating income | $84.58M | $74.75M | $68.08M | $94.76M | $92.16M | $88.13M |
| Income tax | $22.54M | $19.31M | $18.62M | $23.92M | $25.25M | $22.94M |
| Net income | $66.30M | $64.24M | $52.49M | $71.76M | $75.78M | $70.89M |
| EPS (diluted) | $4.84 | $4.46 | $3.57 | $4.86 | $5.00 | $4.65 |